NDC 72694-954

ONCASPAR

Pegaspargase

ONCASPAR is a Intramuscular; Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Servier Pharmaceuticals Llc. The primary component is Pegaspargase.

• Product ID: 72694-954_030c8653-7dba-49ee-94d7-e94175d3efdf
• NDC: 72694-954
• Product Type: Human Prescription Drug
• Proprietary Name: ONCASPAR
• Generic Name: Pegaspargase
• Dosage Form: Injection, Solution
• Route of Administration: INTRAMUSCULAR; INTRAVENOUS
• Marketing Start Date: 2020-01-02
• Marketing Category: BLA / BLA
• Application Number: BLA103411
• Labeler Name: Servier Pharmaceuticals LLC
• Substance Name: PEGASPARGASE
• Active Ingredient Strength: 750 [iU]/mL
• Pharm Classes: Asparaginase [CS],Asparagine-specific Enzyme [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 72694-954-01

1 VIAL, SINGLE-USE in 1 CARTON (72694-954-01) > 5 mL in 1 VIAL, SINGLE-USE

• Marketing Start Date: 2020-01-02
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 72694-954-01 [72694095401]

ONCASPAR INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA103411
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2020-01-02

Drug Details

Active Ingredients

Ingredient	Strength
PEGASPARGASE	750 [iU]/mL

Pharmacological Class

• Asparaginase [CS]
• Asparagine-specific Enzyme [EPC]

NDC Crossover Matching brand name "ONCASPAR" or generic name "Pegaspargase"

NDC	Brand Name	Generic Name
0944-3810	ONCASPAR	Pegaspargase
72694-954	ONCASPAR	Pegaspargase